Document is current
Any future updates will be listed below
-
Authors
Qin, Albert
Ho, Ming-Chih
Tsai, Chan-Yen
Liu, Chun-Jen
Chen, Pei-Jer https://orcid.org/0000-0001-8316-3785
-
Funding
Funding for this research was provided by:
PharmaEssentia Corporation
- License Information
-
More Information
Article History
Received: 20 September 2024
Accepted: 12 March 2025
First Online: 5 April 2025
Declarations
:
: C-Y Tsai works for PharmaEssentia Corporation and A Qin serves as the chief medical officer of PharmaEssentia. P-J Chen serves as a consultant for PharmaEssentia. Other authors declare no conflicts of interest.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study.
